| Biomarker ID | 1215 |
| PMID | 24080222 |
| Year | 2013 |
| Biomarker | PCA3 + Multiparametric MRI |
| Biomarker Basis | Expression Based |
| Biomolecule | Others |
| Source | Urine + Technique |
| Subjects | Humans |
| Regulation | PCA3 Upregulated in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Prostate Cancer Vs Normal Prostate |
| Type of Biomarker | Diagnostic |
| Cohort | 71 consecutive patients with clinically suspected PCa were included in the study. 68 had PCa and 95 did not. |
| Senstivity | NA |
| Specificity | NA |
| AUC | 0.808 (95% CI: 0.742-0.847) |
| Accuracy | NA |
| Level Of Significance | NA |
| Method Used | NA |
| Clinical | No |
| Remarks | Predictor is Base model + PCA3+ MSRI. Base Model = age, PSA level, and DRE findings |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |